Local media highlight Stroke Awareness Month
May 18, 2022
The University of Cincinnati's Eva Mistry and Pooja Khatri were recent guests on local news programs to discuss National Stroke Awareness Month.
May 18, 2022
The University of Cincinnati's Eva Mistry and Pooja Khatri were recent guests on local news programs to discuss National Stroke Awareness Month.
May 23, 2022
The University of Cincinnati's Caleb Adler discussed the recent death by suicide of singer Naomi Judd, risk factors for suicide and resources available for those struggling with mental health issues.
July 25, 2022
The University of Cincinnati's Hyacinth I. Hyacinth was a guest on 55KRC's Simply Medicine program to discuss his research into sickle cell disease, stroke and cognitive impairment.
July 26, 2022
The University of Cincinnati's Jenni E. Farrow, MD, was featured in a segment on 55KRC's Simply Medicine program to discuss ADHD.
August 1, 2022
Genetic Engineering & Biotechnology News featured the research of the University of Cincinnati's Agnes (Yu) Luo, PhD, who recently published a journal article showing a drug helped repair nervous system damage in animal models of stroke.
June 28, 2022
MSN highlighted the University of Cincinnati's Jordan Kharofa and his recent research on how diet and the microbiome affect colorectal cancer risks in young populations.
August 11, 2022
The University of Cincinnati's Joseph Broderick, MD, provided comments in a TCTMD article reviewing the results of a recent study that found administering the drug tirofiban before endovascular thrombectomy does not improve functional outcomes in patients.
August 10, 2022
Medium featured the research of the University of Cincinnati's Jiajie Diao, PhD, who recently published a paper showing early results that light-activated proteins can help normalize dysfunction within cells.
September 28, 2022
The University of Cincinnati's Alberto Espay, MD, was featured in an NBC News article reporting on results from a phase three Alzheimer's drug trial.
November 29, 2022
The University of Cincinnati's Alberto Espay was featured in a Financial Times article discussing the new Alzheimer's drug lecanemab.